The Canadian COVID‑19 Funded Research Database

Back to main page

Displaying 81 through 90 of 130 results (Download Results)

Show results per page

COVID-19 Variant Network – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Houghton, Michael | University of Alberta | Operating Grant | $100,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Impact of Aerosol Box Use on Patterns of Healthcare Provider and Environmental Contamination during Aerosol Generating Medical Procedures: A Multicenter Study

Cheng, Adam | The University of Calgary | Project Grant | $248,625

CIHR Alberta 2021

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

West, Lori J | University of Alberta | Operating Grant | $482,935

CIHR Alberta 2021

COVID-19 Variant Supplement – Inferring undiagnosed sources of COVID‑19 infections using viral genomes

Long, Quan | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

Proof of concept of wastewater-based surveillance for SARS-COV2 to mitigate secondary COVID‑19 disease transmission in First Nations in Alberta

Parkins, Michael D | The University of Calgary | Other | $200,000

CIHR Alberta 2021

Inferring undiagnosed sources of COVID‑19 infections using viral genomes

Long, Quan | The University of Calgary | Operating Grant | $99,000

CIHR Alberta 2020

Wastewater surveillance of SARS-COV2 to enable real-time clinical case-finding in Calgary

Parkins, Michael D | The University of Calgary | Operating Grant | $505,310

CIHR Alberta 2020

Clinical Characteristics and Outcomes of Children Potentially Infected by SARS-CoV-2 Presenting to Pediatric Emergency Departments

Freedman, Stephen B | The University of Calgary | Operating Grant | $788,631

CIHR Alberta 2020

Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Ng, Kenneth K | The University of Calgary | Operating Grant | $416,000

CIHR Alberta 2020

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback